奋斗

China's pharmaceutical industry sees accelerated innovation breakthroughs in H1_我的网站

A |     伊朗官宣“全面进攻”，20万大军剑指科威特，特朗普却要伊朗投降！自美伊冲突陷入到了一个“深水区”后，特朗普在接受媒体采访时就表示，他会要求“伊朗举白旗投降”，否则伊朗将面临美军的猛烈重击。

B |     (ECNS) -- China's pharmaceutical industry accelerated innovation in the first half of this year, with domestic companies steadily improving their R&D capabilities and growth momentum continuing to strengthen, data showed.    China's first broad-spectrum targeted anticancer drug entered clinical use at major hospitals across the country this year. It took only eight months to go from submission to market approval.    A total of 38 innovative drugs were approved for marketing in China in the first half, of which 31 were developed domestically, more than 80% of the total. Eleven drugs featuring new targets or new mechanisms were all developed independently by domestic companies, producing a number of world-first innovations. By the end of 2025, China had 4,751 innovative drugs under development, one-third of the global total and the largest pipeline of any country.    Behind this concentration of results lies a steadily strengthening industrial base. China has a complete pharmaceutical supply chain. It is not only the world's largest producer of active pharmaceutical ingredients but has also built a production system covering every pharmaceutical category.    This year, digital, intelligent, and green technologies have driven the industry's transformation and upgrading.     At a biopharmaceutical company in Shanxi Province, a newly built AI-powered bio-computing center can identify the structures of millions of protein functional domains in a short time, screening out ineffective molecules directly.    To date, China has supported 21 pharmaceutical firms in building excellent-level smart factories and has cultivated more than 300 green factories. In the first half, the added value of pharmaceutical enterprises above the designated scale grew 6.4% year on year, and exports held strong.    The world's first chemotherapy-sparing drug for gastric cancer, launched this year, had already earned overseas revenue through licensing deals before it reached the market, and is now exported to multiple countries and regions.    In the first half, the total value of China's innovative drug out-licensing deals reached $110 billion, the industry's export delivery value grew 9% year on year, and high-value-added products made up nearly 20% of the total.        (By Tang Yuxian)                    。然而，就在特朗普发表这一威胁言论后，据路透社及多方消息8月19日证实，伊朗革命卫队已经不再满足与美军进行小规模的暗中较量，一份涉及20万兵力的绝密作战计划近期意外被曝光，尤其是伊朗准备打击目标不仅剑指科威特，同时霍尔木兹海峡下方的7根海底光缆，也是伊朗军方重点打击的目标之一。        据伊朗知情人士透露，拥有近20万兵力的伊朗伊斯兰革命卫队，已经制定了一套全新的先发制人打击计划。按照伊朗军方预定的打击方案来看，一旦美伊战火再燃，伊朗革命卫队将率先动用武力全面封锁海峡，并出动特种部队破坏海峡下方的7根海底光缆，如此一来，不仅美国华尔街经济市场会面临巨震，就连特朗普也会因为擅自对伊朗开战，从而遭到美国国会的压力。此外伊朗还单独为打击科威特和巴林制定了一套战斗行动，特别是有伊朗官员表示，伊朗高层制定的打击行动中，甚至还考虑直接在科威特境内发动地面军事打击。        有军事专家表示，伊朗这种“玉石俱焚”的强硬态度，也进一步证实伊朗在外交上的努力，已经陷入僵局。由于伊朗高层怀疑美以两国正在就“所谓谈判”实施缓兵之计，并准备利用这个缓冲期来加大武器弹药生产，从而为后续对伊发动战争做准备，因此伊朗此次曝出20万兵力作战计划，无疑就是在向美以两国发出“战争警告”。

C | 面对伊朗的强硬姿态和武力回应，特朗普也立即对此做出了表态。        根据网上最新消息披露，特朗普在接受福克斯新闻采访时，他直接撕掉了外交伪装，特朗普明确表示：“要求伊朗举起白旗投降。”首先特朗普指出他不会延长今年6月签署的谅解备忘录，这就意味着，美伊双方最后的缓冲带已经消失。此外特朗普声称在解决伊朗问题上“没有时间表”，且不考虑大选等政治因素。        最关键的就是，特朗普甚至罕见地公开威胁中立国阿曼，表示“如果阿曼敢阻挠，美军必将对其施以重击”，所以从这里就可以看出，特朗普在打击伊朗的态度上，依旧保持着极限施压的态度。但诡异的就是，当特朗普对伊朗发出武力威胁后，他又承认美伊之间存在“秘密沟通渠道”，并称他自己“不急于解决”伊朗问题，如此一来，美伊谈判还是充满了很大的“变数”。        值得一提的就是，当伊朗20万兵力作战计划曝出后，以色列就认为伊朗是在“虚张声势”。但同时部分以色列官员又不得不承认，伊朗军方的动员速度远超预期，这也让他们感到了前所未有的压力。此外科威特、巴林等国在得知该消息后，也全部做好了应对伊朗革命卫队的准备。只不过这些海湾国家又不得不接受一个残酷的现实，那就是伊朗并没有被击败，而且伊朗对霍尔木兹海峡的控制力度，反而进一步巩固了。特别是霍尔木兹海峡作为全球石油运送的生命线，一旦美军在此对伊朗发动大规模战争，那么全球油价和经济市场，必将面临一场毁灭性冲击，而这个后果无论是伊朗还是美国，都是无法承受的。

D | 返回，查看更多。

Current article:http://iyu0vej.dinggaxilianmaiyuejienianguai.shop/ay8ic8/d2a.html

Published on:18:21:31